A stunning new disclosure by journalist Cynthia Janak reveals that Gardasil (HPV) vaccine dramatically increases the risk of pre-cancerous cervical lesions if injected into girls/women who are already infected with the sero-types contained in the vaccine.
Janak’s excellent article, Gardasil-my error is the smoking gun , also highlights the accumulated adverse reactions, injuries and deaths associated with the new human papilloma virus vaccine aggressively marketed as a cervical cancer preventive and now being injected into thousands of Canadian and American girls.
Long time VRAN member Susan Fletcher has launched a media campaign in her area (coastal British Columbia) by sending the following letter to media outlets. Attached to the letter is our letter to Dr. David Butler-Jones, Canada’s Chief Medical Officer of Health. We urge you to take a similar action in your area. Please send this letter or a similar one along with VRAN’s letter to Dr. Butler-Jones to media people in your area, as well as to the medical officer of health in charge of your health district.
(Addressed to media outlets)
A letter marked “URGENT” has been sent to Canada’s Chief Officer of Public Health, Dr David Butler-Jones. It cites a document submitted to the US FDA in 2006. The document shows that the vaccine, ‘Gardasil’, increased the risk of cervical cancer by 44.6 % for females who, at the time of vaccination, were infected with the same strains of HPV as are used in the vaccine.
HPV (human papillomavirus) is sexually transmitted. But skin-to-skin contact alone can also allow transfer. This means that no female can be absolutely certain they don’t carry vaccine-strain HPV unless they have been tested for it using the latest highly sensitive and specific testing methods. School-based HPV vaccine programs are already in place in much of the country and the vaccine has also been recommended for females up to 26 yrs old.
The letter, sent by Vaccination Risk Awareness Network Inc, asks for immediate attention to this matter. It states that all use of ‘Gardasil’ must be halted and that, henceforth, only females who can be accurately screened and found to be absent of HPV prior to vaccination should be considered candidates for receiving this vaccine.
Read the entire article here.